Eileen Rojas

With $45 million in new funding for Alzheimer’s research, the National Institutes of Health shows support for three drug therapies being studied by Roche and Eli Lilly.

With solid results during the second quarter, Tiffany upped its 2013 earnings guidance, while rivals Signet Jewelers and Pandora also expect higher earnings by year-end.

The introduction of smart watches by tech companies could lead to a decline in demand for designer-label watches sold by retailers like Fossil and Movado.

If the recent uptick in housing demand lasts, shares of homebuilders present a good opportunity to invest in the real estate market.

After reporting second-quarter results, The Fresh Market expects short-term flat margin growth while it revs up its store openings.

Joining publicly traded peers Regal Entertainment and Cinemark Holdings, AMC Entertainment is set to file a $400 million initial public offering.

China’s banks have reported concerns of rising bad loans from several highly leveraged sectors, like the solar panel market.

Whole Foods is expanding its product selection beyond its natural and organic fare even as competitors also look to attract more customers.

As Priceline.com shares inch closer to $1,000 a share, the stock may boldly go where no stock has gone before.

Food companies, such as Tyson Foods and Smithfield Foods, have suspended certain drugs used to add weight to animals amid health and economic concerns.

With unprofitable results in China, Tesco has decided to scale down its operations and partner with a local retailer.